TDOC Teladoc Health Inc.

Teladoc Health Makes A1C Testing Easier for Members with Diabetes

Teladoc Health Makes A1C Testing Easier for Members with Diabetes

At-Home Testing Improves Diabetes Care & Control for Individuals, Providers & Payers Alike

PURCHASE, NY, Aug. 10, 2022 (GLOBE NEWSWIRE) -- (NYSE: TDOC), the global leader in whole-person care, announced today the addition of a home A1C testing program to its Livongo by Teladoc Health chronic care solution, making it easier for members to manage and control their diabetes. Livongo by Teladoc Health members will have the option to receive at-home A1C tests provided by LetsGetChecked, a leading healthcare solutions company that enables providers to administer diagnostics and care directly into the homes of patients. The announcement comes as new company data shows that 58% of members opt for the at-home service when given the chance, with a three to four times greater consumer test return rate than other options on the market.

Coupled with the highly successful Livongo by Teladoc Health diabetes management program and whole-person integrated programs to address hypertension, weight, mental health and other frequent comorbidities, 87% of members using the in-home test reported a controlled A1C of 8% or less. For context, the commercial health plan average was 54%[1] of members having a controlled A1C of 8% or less, reinforcing the positive impact of the Teladoc Health program.

The results of the new at-home testing program are good news for individuals living with diabetes as well as those providing and purchasing their care. At-home testing closes gaps in care and outcomes reporting, improving clinical quality and streamlining the sharing of more complete data with HEDIS and other measures critical to both quality improvement and reimbursement.

“Meeting people where they are is paramount for enabling better clinical outcomes,” said Vidya Raman-Tangella, chief medical officer at Teladoc Health. “Social and environmental factors account for 50-60% of health, and we are addressing persistent challenges by offering in-home testing. The data gathered by giving more people necessary tools will help us to create actionable insights that fuel a more individualized approach to health care.”

Livongo by Teladoc Health members receive the at-home A1C tests – also known as the hemoglobin A1C or HbA1c test – with one-click on their blood glucose meters. A1C is one of the commonly used tests to diagnose pre-diabetes and diabetes, and the main test to help members and their care teams manage diabetes. Individuals self-administer the sample blood collection via finger prick, and based on their results, are offered personalized next steps aimed to help members lower their A1C.

“At-home testing will not only help members better understand their risk, but better manage their conditions and live their healthiest lives on their own terms,” said Kelly Bliss, U.S. Group Health President at Teladoc Health. “For the more than 37 million people in the United States living with diabetes, this is a quick and effortless way for us to engage with members, at the moment they are managing their diabetes.”

The diagnostic testing, provided by LetsGetChecked, is key to ensuring equitable access to care as many populations may not have easy access to a physician or specialist who can perform a check-up or administer these tests. These at-home tests are also often used as a supplement to routine Livongo by Teladoc Health remote diabetes monitoring, which was recently proven to improve health and blood glucose measures regardless of a member’s socioeconomic status.

“The vertically integrated and modular LetsGetChecked platform plays an essential role in reaching underserved or geographically-isolated individuals who often face significant barriers to routine and recommended testing,” said Peter Foley, Founder & CEO of LetsGetChecked. “Through our collaboration with Teladoc Health, we will increase access to care and provide data enabled insights on population-based health initiatives, a particularly critical tool to address the prevalence of chronic health issues.”

About Teladoc Health

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked #1 among direct-to-consumer telehealth providers in the J.D. Power 2021 U.S. Telehealth Satisfaction Study, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit  or follow  on Twitter.

About LetsGetChecked

LetsGetChecked is a global healthcare solutions company that provides the tools to manage health from home through direct access to diagnostic testing, virtual care, and medication delivery for a wide range of health and wellness conditions. LetsGetChecked’s end-to-end model includes manufacturing, logistics, lab analysis, clinician support, and prescription fulfillment. Founded in 2015, the company empowers people with accessible health information and care to live longer, happier lives.

  

LetsGetChecked is available nationwide in the United States, the United Kingdom, and most EU countries. It is co-headquartered in Dublin and New York. For more information, please visit  or follow @LetsGetChecked onTwitter.

Contact

Carolyn W. Edwards



Source: Teladoc Health, Inc. – General



EN
10/08/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teladoc Health Inc.

 PRESS RELEASE

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 30...

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees. Effective April 30, 2025, in connection with the acquisition of Uplift Health Technologies, Inc., four employees of Uplift Health were granted awards of restricted stock units covering an aggregate of 215,028 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”). The restricted stock units vest, ...

 PRESS RELEASE

Teladoc Health Reports First Quarter 2025 Results

Teladoc Health Reports First Quarter 2025 Results PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 (“First Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 (“First Quarter 2024”). First Quarter 2025 Highlights First Quarter 2025 revenue of $629.4 million, down 3% year-over-yearFirst Quarter 2025 net loss of $93.0 million, or $0.53 per share, including a pre-tax goodwill i...

 PRESS RELEASE

Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental He...

Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits Acquisition Broadens Access to Virtual Mental Health Services with In-Network Health Plan Relationships Representing More Than 100 Million Covered Lives PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has acquired UpLift, an innovative and tech-enabled provider of virtual mental health therapy, psychiatry and medication management services.    The acquisition supports the company’s strategy ...

 PRESS RELEASE

Teladoc Health to Announce First Quarter 2025 Financial Results

Teladoc Health to Announce First Quarter 2025 Financial Results PURCHASE, NY, April 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 309585. For international participants, please visit the ...

 PRESS RELEASE

Teladoc Health Introduces Next Generation Cardiometabolic Health Progr...

Teladoc Health Introduces Next Generation Cardiometabolic Health Program New resources aim to improve population health and prevent the progression of diabetes, hypertension and obesity PURCHASE, NY, April 08, 2025 (GLOBE NEWSWIRE) -- (NYSE: TDOC), the global leader in virtual care, today introduced its next generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension and obesity. Building on the company’s industry-leading chronic condition management programs, the new offering is designed to support optimal cardiometabol...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch